Karpinar DP, Balija MB, Kügler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, Kumar A, Riedel D, Fichtner L, Voigt A, Braus GH, Giller K, Becker S, Herzig A, Baldus M, Jäckle H, Eimer S, Schulz JB, Griesinger C, Zweckstetter M. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J. 2009 Oct 21;28(20):3256-68. PubMed.
Recommends
Please login to recommend the paper.
Comments
Comment posted on PD Online Research by Markus Zweckstetter, "What species of alpha-synuclein should be targeted therapeutically?"
Make a Comment
To make a comment you must login or register.